What is the recommended dose of Augmentin (amoxicillin/clavulanic acid) for the treatment of otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for Otitis Media

For acute otitis media in children, use high-dose amoxicillin-clavulanate (Augmentin) at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate (14:1 ratio) divided into 2 doses daily. 1, 2

When to Use Augmentin vs. Amoxicillin Alone

Augmentin should be your first-line choice in three specific scenarios:

  • Recent amoxicillin exposure: Child received amoxicillin within the previous 30 days 1, 2
  • Concurrent conjunctivitis: The otitis-conjunctivitis syndrome suggests β-lactamase-producing organisms 1
  • Treatment failure: Initial amoxicillin therapy failed after 48-72 hours 1, 2

Otherwise, standard high-dose amoxicillin (80-90 mg/kg/day) remains first-line for uncomplicated acute otitis media. 1, 2

Specific Dosing Details

The 14:1 formulation (90/6.4 mg/kg/day) is critical because it provides adequate coverage for resistant pathogens while causing significantly less diarrhea than older 7:1 formulations. 1

  • Frequency: Divide total daily dose into 2 doses (twice daily) 1, 3
  • Duration: Typically 10 days for standard treatment 4, 5
  • Maximum dose: Follow manufacturer's maximum adult dosing limits

Why This Specific Formulation Matters

The high-dose 14:1 ratio formulation achieves several goals:

  • Covers penicillin-resistant Streptococcus pneumoniae: Achieves middle ear fluid levels exceeding the MIC for intermediately resistant (MIC 0.12-1.0 μg/mL) and many highly resistant strains (MIC ≥2 μg/mL) 1, 6
  • Covers β-lactamase producers: Effective against β-lactamase-producing Haemophilus influenzae (58-82% of strains) and Moraxella catarrhalis 1, 6
  • Reduces gastrointestinal side effects: The 14:1 ratio causes substantially less diarrhea (8.7-9.6%) compared to the older 4:1 ratio formulation (26.7%) 1, 5

Efficacy Evidence

High-dose amoxicillin-clavulanate demonstrates superior bacteriologic eradication:

  • 96% eradication rate for S. pneumoniae at days 4-6 of therapy 1
  • 77.8-84.6% successful bacteriological response at end of therapy 4
  • Clinical cure rates of 86.5-94% comparable to or better than alternatives 4, 3

Twice Daily vs. Three Times Daily Dosing

Use twice-daily dosing - it provides equivalent efficacy with better compliance and fewer side effects:

  • No difference in clinical cure rates between twice and three times daily dosing (RR 1.02,95% CI 0.95-1.09) 1, 3
  • Higher compliance: 82.8% with twice daily vs. 73.3% with three times daily 4
  • Less diarrhea: 9.6% with twice daily vs. 26.7% with three times daily 4, 5

Common Pitfalls to Avoid

  • Don't use lower-dose formulations: The standard 40/10 mg/kg/day formulation lacks adequate coverage for resistant S. pneumoniae 1
  • Don't use the wrong ratio: Older 7:1 or 4:1 formulations cause significantly more diarrhea without improved efficacy 1, 5
  • Don't extend to three times daily: This increases side effects without improving outcomes 4, 5, 3

Adult Dosing

For adults with otitis media (less common), use the pharmacokinetically enhanced formulation of 2000/125 mg twice daily. 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.